Endoscopic Sinus Surgery for Recurrent Acute Rhinosinusitis: A Randomized Clinical Trial

医学 外科 鼻内镜手术 耳鼻咽喉科 保守治疗 生活质量(医疗保健) 鼻窦炎 随机对照试验 不利影响 慢性鼻-鼻窦炎 临床试验 内窥镜检查 医疗 回顾性队列研究 前瞻性队列研究 自然史 保守管理 窦(植物学) 意向治疗分析 年轻人 病历
作者
Heidi Kaski,Antti I. Alakärppä,Aleksi Laajala,Paulus Tokola,Tomi Penna,Ulla Lantto,Pasi Petteri Ohtonen,Olli‐Pekka Alho
出处
期刊:JAMA otolaryngology-- head & neck surgery [American Medical Association]
卷期号:152 (8): 776-776 被引量:2
标识
DOI:10.1001/jamaoto.2026.1537
摘要

Importance: Recurrent acute rhinosinusitis (RARS) decreases quality of life. The effects of endoscopic sinus surgery (ESS) in RARS are understudied. Objective: To compare the quality of life between patients with RARS who had surgery and medical treatment vs medical treatment alone. Design, Setting, and Participants: This is an open-label randomized clinical trial with 2 parallel groups with a 6-month follow-up. Patients referred to Oulu University Hospital Otolaryngology Clinic between May 2020 and June 2024 were recruited to participate in the trial. Inclusion criteria were adults with physician-diagnosed RARS episodes occurring at least 3 times during the past 6 months, 4 times during the past year, or twice per year for 3 consecutive years. Conservative treatment had been insufficient for symptom relief. Data collection and analyses were planned before commencing recruitment. Data collection was performed from May 2020 to December 2024, and analysis from January 2025 to January 2026. Interventions: The operative group received ESS and medical treatment, and the conservative group received medical treatment alone. Main Outcomes and Measures: The main outcome was the difference between groups in mean SinoNasal Outcome Test 22 (SNOT-22) score change from baseline to a 6-month follow-up. The SNOT-22 questionnaire measures rhinosinusitis-related quality of life. Sinonasal symptoms, number of health care visits, antibiotic courses, absences from work or study, and the adverse effects of operative treatment were also studied. Results: A total of 59 patients (mean [SD] age, 40 [14] years; 52 women [88%]) were recruited, 30 in the operative and 29 in the conservative group. Intention-to-treat analysis of the primary outcomes was performed. The mean SNOT-22 score change from baseline to 6 months was greater after ESS compared to medical treatment only (difference, 22.41 points (95% CI, 13.67-31.10 points). Per-protocol analyses of secondary outcomes supported the primary findings for the most part. Only 4 patients received intervention for an operative complication (3 infections, 1 synechia with septal perforation). Conclusions and Relevance: In this randomized clinical trial, ESS improved patient-related outcomes at a 6-month follow-up in adults with RARS. Conservative treatment had no clinically meaningful effect. These results suggest that ESS is an effective treatment without major problems. Trial Registration: ClinicalTrials.gov Identifier: NCT04241016.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无极微光的应助被是我呀吼采纳,获得20
1秒前
明理乾发布了新的文献求助10
1秒前
1秒前
FG发布了新的文献求助10
2秒前
史迪仔完成签到 ,获得积分10
2秒前
xiaobai发布了新的文献求助10
3秒前
西红柿完成签到,获得积分10
3秒前
大模型的应助被开朗紫采纳,获得10
3秒前
研友_ndvWy8完成签到,获得积分10
4秒前
5秒前
6秒前
7秒前
莓莓发布了新的文献求助10
8秒前
FG完成签到,获得积分10
8秒前
爆米花的应助被简单山水采纳,获得10
8秒前
上官若男的应助被雾潋采纳,获得10
9秒前
Kiss完成签到,获得积分10
11秒前
cdercder的应助被fzt采纳,获得10
11秒前
11秒前
GBY完成签到,获得积分10
12秒前
LIUJIAWEI发布了新的文献求助10
13秒前
Maestro_S的应助被一呆采纳,获得10
13秒前
GBY发布了新的文献求助10
14秒前
BINBIN完成签到,获得积分10
16秒前
顺利的盼曼完成签到 ,获得积分10
17秒前
我的djwhjja发布了新的文献求助10
17秒前
1234完成签到,获得积分10
19秒前
creach完成签到,获得积分10
19秒前
科研通AI6.3的应助被WZJ采纳,获得10
20秒前
悦耳凤灵完成签到,获得积分10
21秒前
Jasper的应助被李飞龙采纳,获得10
21秒前
领导范儿的应助被xiaobai采纳,获得10
24秒前
Jun的应助被GBY采纳,获得10
24秒前
24秒前
25秒前
我的djwhjja完成签到,获得积分10
25秒前
25秒前
光亮发卡发布了新的文献求助10
25秒前
李健的小迷弟的应助被yosh采纳,获得10
25秒前
creach发布了新的文献求助10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568